H2FPEF Score Improves Heart Failure Prediction in HCM
The H2FPEF score, a prognostic tool for diagnosing heart failure with preserved ejection fraction, proved useful for risk stratification in HCM.
Read MoreOct 1, 2024
The H2FPEF score, a prognostic tool for diagnosing heart failure with preserved ejection fraction, proved useful for risk stratification in HCM.
Read MoreSep 18, 2024
Type 2 diabetes impacted left ventricular and atrial function in patients with hypertrophic cardiomyopathy, emphasizing the need for diabetes surveillance.
Read MoreSep 12, 2024
4D flow MRI may be a viable, non-invasive alternative to right heart catheterization for measuring blood flow in patients with pulmonary arterial hypertension.
Read MoreSep 3, 2024
A study published in ESC Heart Failure identified seven influencing factors and two prognostic factors for end-stage hypertrophic cardiomyopathy.
Read MoreSep 3, 2024
Per-segment indexed apical wall thickness thresholds were accurate in detecting apical hypertrophy and could help diagnose apical hypertrophic cardiomyopathy.
Read MoreAug 25, 2024
Matthew Budoff, MD, reviews key points from the 2024 HCM guidelines, including recreational exercise, AF, and ICD risks, and discusses the possible impacts.
Read MoreAug 24, 2024
High FIB-4 scores were linked to heightened risks for cardiovascular comorbidities, cardiac death, and MACE in patients with hypertrophic cardiomyopathy.
Read MoreAug 23, 2024
Percutaneous intramyocardial septal radiofrequency ablation was efficacious and safe for patients with obstructive hypertrophic cardiomyopathy.
Read MoreAug 22, 2024
New findings shed light on optimal pre-surgical myectomy for obstructive hypertrophic cardiomyopathy imaging techniques and measurement types.
Read MoreAug 21, 2024
Personalized distal ventricular pacing therapy reduced obstruction and improved exercise performance in patients with HCM with refractory, symptomatic LVMCO.
Read More